S. Hanauer
Impact in
- Genetics top 5%
- Inflammatory Bowel Disease
- Pharmacology top 10%
- Drug-Induced Hepatotoxicity and Protection
- Inflammatory mediators and NSAID effects
Papers in
- Genetics 25
- Inflammatory Bowel Disease 25
-
- Pharmacogenetics and Drug Metabolism 1
- Drug-Induced Hepatotoxicity and Protection 1
- Co-authors
- MALCOLM G. ROBINSON (2 shared papers)John P. Cello (1 shared paper)Michael A. Safdi (1 shared paper)Walter M. Roufail (1 shared paper)Bret A. Lashner (1 shared paper)Paul Rutgeerts (6 shared papers)Helen S. Te (1 shared paper)Alfred L. Baker (1 shared paper)
- Journals
- Gastroenterology (9 papers)Inflammatory Bowel Diseases (5 papers)Alimentary Pharmacology & Therapeutics (4 papers)The American Journal of Gastroenterology (2 papers)Colorectal Disease (1 paper)
- Partner nations
- United StatesCanadaGermany
In The Last Decade
S. Hanauer
27 papers receiving 902 citations
Peers
Comparison fields: 5 of 52
- Genetics 753
- Pharmacology 34
- Pharmaceutical Science 24
- Family Practice 8
- Oncology 66
Countries citing papers authored by S. Hanauer
This map shows the geographic impact of S. Hanauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Hanauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Hanauer more than expected).
Fields of papers citing papers by S. Hanauer
This network shows the impact of papers produced by S. Hanauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Hanauer. The network helps show where S. Hanauer may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Hanauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Mesalamine capsules for treatment of active ulcerative colitis: results of a controlled trial. Pentasa Study Group. | 1993 | 242 |
| 2 | 2000 | 139 | |
| 3 | Colon cancer surveillance in chronic ulcerative colitis: historical cohort study. | 1990 | 92 |
| 4 | 1998 | 87 | |
| 5 | 1997 | 75 | |
| 6 | 2005 | 47 | |
| 7 | 2006 | 46 | |
| 8 | Safety of infliximab in clinical trials | 1999 | 33 |
| 9 | 1994 | 30 | |
| 10 | 2005 | 28 | |
| 11 | 2004 | 27 | |
| 12 | 1998 | 21 | |
| 13 | Duration of response following cessation of infliximab therapy for active or fistulizing Crohn's disease | 1999 | 15 |
| 14 | 2006 | 13 | |
| 15 | 1996 | 12 | |
| 16 | 2007 | 12 | |
| 17 | 2005 | 11 | |
| 18 | 1999 | 10 | |
| 19 | 1998 | 6 | |
| 20 | 1997 | 4 |
About S. Hanauer
S. Hanauer is a scholar working on Genetics, Pharmacology, Toxicology, Hepatology and Rheumatology, having authored 28 papers that have together received 966 indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (25 papers), Colorectal Cancer Screening and Detection (1 paper), Pharmacogenetics and Drug Metabolism (1 paper), Rheumatoid Arthritis Research and Therapies (1 paper), Liver Diseases and Immunity (1 paper), Pharmacovigilance and Adverse Drug Reactions (1 paper), Immunotoxicology and immune responses (1 paper) and Drug-Induced Hepatotoxicity and Protection (1 paper). The work is most often cited by research in Genetics (753 citations), Pharmacology (34 citations), Pharmaceutical Science (24 citations), Family Practice (8 citations) and Oncology (66 citations). S. Hanauer has collaborated with scholars based in United States, Canada and Germany. Frequent co-authors include MALCOLM G. ROBINSON, John P. Cello, Michael A. Safdi, Walter M. Roufail, Bret A. Lashner, Paul Rutgeerts, Helen S. Te, Alfred L. Baker, Hari S. Conjeevaram and Thomas D. Schiano. Their work appears in journals such as Gastroenterology, Inflammatory Bowel Diseases, Alimentary Pharmacology & Therapeutics, The American Journal of Gastroenterology and Colorectal Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.